Pharmacotheraphy in chronic obstructive pulmonary disease
This volume considers the application of clinical assessment to the drug development process. Important topics include genetics and sleep-related breathing disturbances in COPD.
Saved in:
| Other Authors: | |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
New York
Marcel Dekker,
2004.
|
| Series: | Lung biology in health and disease
v. 182. |
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- Providing evidence of therapeutic benefit in clinical drug development / Steven Kesten and Theodore J. Witek
- Use of expiratory airflows and lung volumes to assess outcomes in COPD / Gary T. Ferguson
- Exercise testing / Denis E. O'Donnell and Katherine A. Webb
- Sleep-related breathing disturbances in COPD / Walter T. McNicholas
- Airway and alveolar determinants of airflow limitation in COPD / Noe Zamel
- Gas exchange / Antoni Ferrer, Joan Albert Barberá, and Roberto Rodriguez-Roisin
- Genetics of COPD / Jian-Quing He, Ikuma Kasuga, and Peter D. Paré
- Dyspnea / Donald A. Mahler
- Exacerbations of COPD / Jadwiga A. Wedzicha
- Health status measurement in COPD / Paul W. Jones
- Health resource utilization / Mitchell Friedman
- Anticholinergics / Peter J. Barnes
- [beta]-adrenergic receptor agonist bronchodilators in the treatment of COPD / Stephen I. Rennard
- Theophylline and phosphodiesterase inhibitors in COPD / Alicia R. ZuWallack and Richard L. ZuWallack
- Corticosteroids in COPD / Mario Cazzola, Maria Gabriella Matera, and Romain Pauwels
- Antioxidants and protease inhibitors / Mario Cazzola and Maria Gabriella Matera
- An integrated approach to the pharmacological therapy of COPD / Bartolome R. Celli.